Kite Pharma Inc. buy melinda
Start price
31.08.17
/
50%
€160.57
Target price
05.10.17
€166.87
Performance (%)
0.99%
End price
05.10.17
€162.17
Summary
This prediction ended on 05.10.17 with a price of €162.17. During the runtime of the prediction for Kite Pharma Inc. the price only changed by 0.99%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Kite Pharma Inc. | - | - | - | - |
| iShares Core DAX® | -0,05 % | 5,96 % | 7,40 % | 65,85 % |
| iShares Nasdaq 100 | 0,92 % | 3,69 % | 28,14 % | 93,30 % |
| iShares Nikkei 225® | 3,01 % | 6,64 % | 48,89 % | 89,08 % |
| iShares S&P 500 | -0,36 % | 2,75 % | 22,53 % | 71,94 % |
Comments by melinda for this prediction
In the thread Kite Pharma Inc. diskutieren
pharma
Kite Pharma, Inc.KITECéloleucel von Axicabtagène (KTE-C19) (BLA) bei der FDA Entscheidung über die KTE-C19 für Non-Hodgkin-Lymphom 2017.11.29
(Vom Mitglied beendet)